Packaging Operator III
About the job
- Ability to read, write, and communicate in English.
- Ability to use basic shop math, algebra, and basic computer skills.
- A legal right to work in the United States.
- Must pass a drug screen and a background check in accordance with IFF standards.
- Perform complex automatic machine operation functions in multiple work locations to support production goals, quality, and current good manufacturing practice standards.
- Provide peer-level technical guidance to Packaging Operators to ensure consistent operation and adherence to procedures.
- Act as a subject-matter resource for troubleshooting equipment and resolving routine process issues.
- Serve as a senior operator resource for questions related to equipment setup, documentation, accuracy, and current good manufacturing practice expectations.
- Provide mentorship to new or less-experienced team members.
- Operate advanced automated packaging equipment across multiple workstations while following detailed work instructions.
- Troubleshoot mechanical and process issues to maintain efficiency and minimize downtime.
- Maintain current good manufacturing practice compliance through accurate documentation, inspections, and annual re-qualification.
- Ensure workplace safety by identifying hazards, maintaining cleanliness, and following personal protective equipment requirements.
- Clean and break down equipment, including machines, tools, and surrounding areas.
- Recognize and respond to out-of-control events by stopping operations and resuming only after resolution.
- Train new operators and participate in task forces focused on process improvement.
- Collaborate with engineering, maintenance, and production leadership.
- Perform other duties assigned.
- Experience with Food and Drug Administration/current good manufacturing practice compliance is preferred.
- A clear focus on high-quality production.
- Ability to work independently and within a close-knit team environment.
- Good communication, interpersonal, and customer service skills.
- A positive demeanor.
- Dependability demonstrated through attendance and job duties.
- Continuous improvement and a willingness to challenge existing processes.
About the company
International Flavors & Fragrances Inc. operates as a vertically integrated supplier of ingredients and formulations across four main areas: Nourish (food and beverage ingredients and solutions), Health & Biosciences (sustainable, bio-based solutions), Scent (fragrances for fine perfumery, personal care, and home care), and Pharma Solutions (functional excipients and active pharmaceutical ingredients for pharma and dietary supplements). Its products go from research and development through manufacturing, enabling customers to formulate foods, cosmetics, and medicines. The company differentiates itself by concentrating resources on higher-margin segments (Scent, Nourish flavors, Health & Biosciences) and by streamlining its portfolio through strategic divestitures to improve margins and return on invested capital. The overarching goal is steady margin expansion and stronger ROIC while delivering integrated, end-to-end solutions to its global customer base.
Company Size
10,001+
Company Stage
IPO
Headquarters
New York City, New York
Founded
1889
Get referred to International Flavors & Fragrances
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 comparable sales grew 6% in continuing operations, driven by volume.
- Scent sales rose 8% comparable currency-neutral, led by fragrance ingredients.
- Omni-Bos PHY launched September 17, 2026, opening dairy enzyme growth in MEA and Asia-Pacific.
What critics are saying
- India's CCI probes IFF for alleged price collusion and anti-poaching since 2024.
- Reuters said CCI recalled its report in July 2026, prolonging penalties and discovery.
- A failed Food Ingredients separation destroys scale and finances the remaining business.
What makes International Flavors & Fragrances unique
- IFF's Science of Performance platform turns fragrance delivery into proprietary, defensible chemistry.
- AQUASCENT, launched September 30, 2026, supports 10%-25% fragrance loads while staying clear.
- IFF combines flavors, scents, and biosciences across global labs and manufacturing.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- 401(k) Company Match
- Paid Vacation
- Performance Bonus
Company News
Lallemand broadens meat processing solutions with IFF cultures acquisition. Key takeaways. * Lallemand acquires IFF's meat cultures portfolio, adding Texel starter and surface cultures, as well as bioprotective cultures. * The deal expands its meat fermentation offering, with supply and technical support continuing during the transition. * The acquisition follows Lallemand's recent expansion in enzyme and microbial technologies through BIO-CAT and Solyve. Lallemand has acquired IFF's meat cultures portfolio, expanding its offering of starter, surface, and bioprotective cultures for meat applications. The deal brings Texel cultures into its Lallemand Specialty Cultures business unit, broadening its range of microorganism-based solutions for food manufacturers. Announced this week, the acquisition adds complementary expertise to Lallemand's existing production, application, and innovation capabilities. Financial terms were not disclosed. The announcement does not specify whether manufacturing sites, personnel, or other assets are included in the transaction, or detail the integration timeline. "We are delighted to welcome this range from IFF into the Lallemand Specialty Cultures portfolio," says Lauriane Fillous, general manager of Lallemand Specialty Cultures. Fillous says the integration complements the company's existing offering and strengthens its ability to support customers with selected microorganisms and technical expertise. Lallemand Specialty Cultures says it will work with customers throughout the transition to maintain continuity of supply, technical support, and service. The business cites 60 years of expertise in meat cultures. Meat bioprotection. In a March 2026 update, Lallemand outlined its Lalcult Protect cultures for meat applications. The company said Protect PA+ uses bacteriocin production to help control Listeria monocytogenes in dry fermented sausages. For fresh meat, Lallemand highlighted Protect CM+, which it said can inhibit L. monocytogenes during storage without affecting color, flavor, or pH. The developments underline its existing focus on microbial safety and sensory quality. Meat reformulation. The acquisition builds on Lallemand's existing work in meat fermentation and bioprotection, including solutions designed to support formulations with reduced or no added nitrates and nitrites. In a 2023 interview with Food Ingredients First, the company outlined Natural Rosé, a combination of yeast ingredients and food cultures developed by its Bio-Ingredients and Specialty Cultures divisions. The concept combines Savor-Lyfe NR 02 and LalCult Carne Rosé - Dry to help maintain sensory quality and food safety when nitrates and nitrites are reduced or removed. The yeast component contributes umami flavor, while cultures help control oxidation. Julia Plateau-Gonthier, Lallemand's dairy, meat, and plant-based category manager at the time, explained that the combination was designed to stabilize meat color. The company also reported testing against Listeria and Salmonella and said protective cultures could be tailored to the production process and finished product. Expanding microbial capabilities. The meat cultures deal follows other moves to broaden Lallemand's fermentation and ingredient capabilities. In August, Foodingredientsfirst reported Lallemand's acquisition of BIO-CAT Enzymes & Microbials, which expanded its enzyme, probiotic, and microbial technologies and strengthened its US manufacturing footprint. The US-based business serves food ingredients, dietary supplements, animal nutrition, agriculture, and industrial biotechnology markets. Last month, Lallemand also established Solyve as a dedicated F&B enzyme business, bringing scientific, manufacturing, and customer support teams into one organization. That move followed its acquisition of the enzyme specialist from France's InVivo group. The latest transaction extends Lallemand Specialty Cultures' meat offering, with the company positioning the expanded portfolio as a platform for further customer collaboration and innovation.
Lallemand expands its cultures offering with the acquisition of IFF's Meat Cultures Portfolio. Posted 13 October, 2026 Image: Lallemand Lallemand, through its Lallemand Specialty Cultures business unit, is pleased to announce the acquisition of the IFF meat cultures portfolio, further expanding its offering. This strategic acquisition reinforces Lallemand Specialty Cultures' commitment to advancing specialty cultures for food applications and enhances its ability to serve the food industry worldwide. Building on 60 years of expertise in meat cultures, Lallemand Specialty Cultures combines strong capabilities in production, applications, innovation, and customer collaboration. The expanded portfolio brings complementary know-how and a broader range of microorganism-based solutions, including Texel starter and surface cultures, as well as bioprotective cultures, strengthening its ability to address diverse meat application needs. "We are delighted to welcome this range from IFF into the Lallemand Specialty Cultures portfolio" said Lauriane Fillous, general manager of Lallemand Specialty Cultures. "This integration strengthens and complements our existing offer, enhancing our ability to support customers with carefully selected microorganism-based solutions, strong technical expertise, and a shared passion for fermentation." Lallemand Specialty Cultures will work closely with customers throughout the transition period to ensure continuity of supply, technical support and service while creating new opportunities for innovation and growth.
IFF introduces AQUASCENT(TM): advanced water-based fragrance technology. Business Wire Published Sep 30, 2026 New innovation from IFF's Science of Performance platform offers greater transparency and olfactive performance for fine fragrance NEW YORK - IFF (NYSE: IFF), a global leader in flavors, fragrances and health and biosciences, today introduced AQUASCENT(TM), a new vegan, water-based carrier for fine fragrance. Crafted from a proprietary formula made with biodegradable materials, AQUASCENT(TM) delivers enhanced olfactive performance and visual clarity for consumers while supporting a more sustainable approach to shipping the product. Story continues below "AQUASCENT(TM) reflects our continued investment in new scent technologies and formats that create compelling fragrance experiences while supporting the industry's growing focus on sustainability," said Sabrya Meflah, president of Fine Fragrance for IFF Scent. "This technology illustrates our ambition to set a new standard for how fragrance is created, delivered and experienced." Top Stories Interested in more newsletters? Browse here. AQUASCENT(TM) is part of IFF's Science of Performance platform, which focuses on solutions that enhance fragrance performance by shaping how scent is delivered and experienced over time. The market for water-based fragrance continues to grow as leading brands launch new water-based products and consumers embrace new scent formats and experiences. IFF web-listening data shows that worldwide Google searches for "water-based perfumes" increased 18% year-to-date, while related TikTok content has generated more than 15 million views. AQUASCENT(TM) supports fragrance loads from 10% to up to 25%, compared with up to 15% for most comparable systems. Achieving this level of fragrance concentration in water-based formulations can be challenging, as fragrance oils can cause products to become cloudy when mixed with water. AQUASCENT(TM) overcomes this issue while maintaining transparency, enabling brands to create high-performance, visually clear fragrances. As a result, fragrance brands can deliver the lastingness and visual elegance consumers associate with fine fragrance products. Formulated without intentionally added ethanol, preservatives or silicone, the technology features a non-sticky formulation with documented skin-hydrating properties for a comfortable skin feel. AQUASCENT(TM) also offers a more resource-efficient approach to transportation. The carrier technology can be supplied as a concentrate alone, allowing fragrance brands to add water during final production rather than transporting it as part of the formula. By reducing the volume and weight of material shipped, this compact format can help lower CO[2] emissions from shipping. "AQUASCENT(TM) approaches water-based fragrance as a complete fine fragrance system, balancing olfactive performance and visual clarity and a concentrated format designed for efficient transportation," said Fatimata Dembele-Kuntzmann, Ph.D., senior technical manager for IFF Scent. "For brands, that means the opportunity to embrace a growing fragrance format without compromising the qualities that define the fine fragrance experience." Story continues below Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in taste, scent and biosciences, we're innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love - advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn,Instagram and Facebook. View source version on businesswire.com:
IFF has launched Omni-Bos PHY, a phytase enzyme designed specifically for dairy cattle. The technology unlocks nutrients already present in feed by breaking down phytate, a compound that binds nutrients and reduces their availability to animals. Traditional phytase enzymes have been used in poultry and swine production but were not designed to withstand dairy cattle's digestive conditions. Omni-Bos PHY helps cows utilise more protein, phosphorus, and minerals from existing feed ingredients, reducing reliance on supplemental nutrients. The product will initially launch in the Middle East, Africa, and Asia-Pacific regions. Global milk production is projected to grow 2% annually over the coming decade, increasing pressure on producers to improve productivity whilst managing feed costs and sustainability targets.
IFF's channel partners extend expertise across the globe. 16 September 2026 in: Home Care IFF's channel partnerships close the gap for home care manufacturers, delivering enzyme innovation to help companies that have historically operated without access to top-tier enzyme science. Through channel partners like IndSpyre Solutions in North America and IMCD across Europe and Latin America, IFF has built a distribution network that circulates expertise, not just products. Quality that travels, speed when it counts. Internal validation testing is the moment of truth for IFF customers bringing a new home care or industrial & institutional formulation to market. IFF's process eliminates surprises during this important stage. Years of methodology alignment, shared training, and mutual investment with channel partners ensures the same tests are run under the same conditions that IFF would run in its own labs, guaranteeing the integrity of the results for each customer. The clock is always running in the home care market, with a typical product facing roughly a one-year development window before the market moves on to something new. IndSpyre and IMCD work proactively to provide their customers with validated solutions and starting formulations benchmarked against leading brand tiers, rather than waiting for challenges to react to. Expertise travels smoothly throughout this network, uncovering trends in isolated supply chains in days, rather than months, offering opportunities to provide solutions sooner. Regional labs, global standards. Behind every validated enzyme-powered home care formulation is rigorous lab work. IFF's channel partners extend this rigor across the globe. IndSpyre's 3,000 sq ft North American home care lab is built to IFF standards. IMCD's newly opened Cologne, Germany facility dedicates 200 sqm to laundry and dish development, reproducing market-relevant methods (e.g., IKW, Ecolabel). And in Brazil, IMCD has become a reference for enzymatic cleaning solutions in a region that was previously without dedicated enzyme support, providing Latin America customers the same quality of technical service as customers anywhere in the world. A complete and trusted path to market. IFF can recommend the right enzyme, but a finished product needs much more, including surfactants, polymers, stabilizers, bio-based options, third-party certifications, and a formulation plan that holds together across the whole ingredient list. IFF's channel partners add complete, tested formulations covering every ingredient on the back of the bottle, with the data to back it up, plus the expertise to make sure sustainability claims actually hold. Channel partnerships rest on mutual expertise and transparent investment. IFF provides enzyme science and application testing, while channel partners contribute formulation knowledge, market access, and broader relationships. Both sides own the results, sustained by regular reporting and shared customer days that keep methods aligned across the global network. Whether it's a boutique brand building its first laundry formula or a regional manufacturer with no lab of its own, IFF's channel partners help close the gap between innovation and impact.